d.oyelaran
TL3 Pharmacist · Lagos, NG
Pharmacist, supply chain and cold chain. I have opinions about excursion logs and I will share them at length if invited.
Joined 1 August 2024 · last posted 6h · groups: pharmacists
150 posts, newest first. Showing up to 150.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #77 · Analytics › HPLC & UHPLC · 28 Jul 2026 · 1 like This follows post #74 rather than contradicting it. This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #69 · Practice › Dosing & titration · 27 Jul 2026 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
What to bring: records that a clinician can actually use Replied, post #9 · Clinical › Prescriber conversations · 20 Jul 2026 · 16 likes Picking up post #6: that is the part I would want checked first. Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #139 · Sourcing › Logistics · 19 Jul 2026 · 0 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #57 · Practice › Interactions · 18 Jul 2026 · 27 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #46 · Start Here › Welcome · 15 Jul 2026 · 4 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #33 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 0 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Pages past their review date, listed — does this still hold? Replied, post #43 · Meta › Wiki maintenance · 8 Jul 2026 · 0 likes post #42 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #46 · Clinical › Prescriber conversations · 6 Jul 2026 · 2 likes post #45 is right about the mechanism and I think understates the practical bit. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #14 · Compounds › Repair & healing peptides · 5 Jul 2026 · 22 likes I read post #12 twice before replying, because I had assumed the opposite. What would change the position on repair peptides: adequately powered, published,…
-
How much context is too much context in a first post? Replied, post #7 · Start Here › How to Ask · 4 Jul 2026 · 10 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #39 · Pharmacology › Pharmacokinetics · 1 Jul 2026 · 0 likes Picking up post #36: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Pooling trials with different estimands Replied, post #59 · Evidence › Meta-analyses · 30 Jun 2026 · 11 likes On post #55 — agreed on the reasoning, with one qualification. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention,…
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #22 · Practice › Administration · 28 Jun 2026 · 1 like Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #64 · Compounds › Tirzepatide · 27 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #73 · Analytics › HPLC & UHPLC · 26 Jun 2026 · 2 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #129 · Practice › Reconstitution · 25 Jun 2026 · 25 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #29 · Compounds › Secretagogues & GH axis · 23 Jun 2026 · 12 likes post #28 is right about the mechanism and I think understates the practical bit. Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #30 · Analytics › Method validation · 15 Jun 2026 · 29 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #37 · Start Here › How to Ask · 12 Jun 2026 · 0 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Follow-up: Sleep quality changes during weight loss Replied, post #43 · Wellbeing › Sleep · 12 Jun 2026 · 12 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
-
Reading a trial's population section before its results Replied, post #102 · Evidence › Trials · 8 Jun 2026 · 19 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Racemisation and why it is invisible to a mass measurement Replied, post #4 · Analytics › Impurities & related substances · 8 Jun 2026 · 28 likes I read post #3 twice before replying, because I had assumed the opposite. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #76 · Evidence › Journal club · 4 Jun 2026 · 2 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Submitting a sample: the process end to end Started this topic · Sourcing › Independent verification · 2 Jun 2026 · 35 likes On the subject in the title: Submitting a sample: the process end to end Working notes rather than a conclusion. I would like to talk about documentation quality as a…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #29 · Evidence › Journal club · 28 May 2026 · 6 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
What a certificate commits its issuer to — the long version Replied, post #10 · Analytics › COA interpretation · 27 May 2026 · 25 likes I read post #8 twice before replying, because I had assumed the opposite. Purity and content are different measurements: purity tells you what proportion of the…
-
The anatomy of a question that gets answered within an hour Replied, post #53 · Start Here › How to Ask · 22 May 2026 · 19 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #14 · Sourcing › Vendor reports · 12 May 2026 · 20 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
Request declined, with reasoning — what changed since Replied, post #37 · Meta › Feature requests · 8 May 2026 · 8 likes Coming back to post #35, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Pancreatitis history and the risk calculus Replied, post #8 · Safety › Contraindications · 7 May 2026 · 12 likes I read post #6 twice before replying, because I had assumed the opposite. Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose…
-
Journal club: is percentage weight change the right endpoint? Replied, post #111 · Evidence › Journal club · 28 Apr 2026 · 0 likes I read post #109 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is…
-
Managing an unplanned gap in supply Replied, post #107 · Access › Shortages · 22 Apr 2026 · 6 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #38 · Compounds › Repair & healing peptides · 16 Apr 2026 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #25 · Evidence › Preprints · 6 Apr 2026 · 22 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #54 · Practice › Administration · 6 Apr 2026 · 13 likes Coming back to post #52, because the follow-up matters more than the original answer. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #40 · Practice › Administration · 4 Apr 2026 · 4 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Grapefruit: why this class is not the class that cares Replied, post #87 · Practice › Interactions · 27 Mar 2026 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
The "under review" status pill and when a moderator applies it Replied, post #12 · Evidence › Preprints · 8 Mar 2026 · 4 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
Measurement error in home scales, with a worked standard deviation Replied, post #20 · Research Methods › Statistics · 8 Mar 2026 · 0 likes P-values and significance: p
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #26 · Research Methods › N-of-1 designs · 2 Mar 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Personal import allowances, compared — a second dataset Replied, post #75 · Access › International · 25 Feb 2026 · 9 likes post #74 is right about the mechanism and I think understates the practical bit. Insurance and coverage: coverage decisions are national. A compound approved in one…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #51 · Clinical › Special populations · 22 Feb 2026 · 0 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #63 · Practice › Dosing & titration · 18 Feb 2026 · 8 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #69 · Sourcing › Vendor reports · 13 Feb 2026 · 0 likes I read post #67 twice before replying, because I had assumed the opposite. Multiple services on one lot: agreement across two independent laboratories is stronger than…
-
Why this subcategory is stricter about sourcing than most Started this topic · Compounds › Secretagogues & GH axis · 12 Feb 2026 · 6 likes Asking directly, because I could not find a straight answer: Why this subcategory is stricter about sourcing than most Session topic: PIONEER 6 ( N Engl J Med , 2019).…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #46 · Practice › Interactions · 7 Feb 2026 · 2 likes I read post #44 twice before replying, because I had assumed the opposite. Separation timing versus clinically important interaction: a separation timing inconvenience…
-
Trifluoroacetate content and its consequences Replied, post #104 · Analytics › Impurities & related substances · 7 Feb 2026 · 0 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
[2026 update] What a good consultation looks like from the other side Replied, post #15 · Clinical › Prescriber conversations · 7 Feb 2026 · 3 likes This follows post #12 rather than contradicting it. Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #43 · Practice › Interactions · 29 Jan 2026 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #96 · Sourcing › Independent verification · 26 Jan 2026 · 14 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #81 · Clinical › Special populations · 25 Jan 2026 · 0 likes Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #64 · Clinical › Special populations · 24 Jan 2026 · 17 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Heterogeneity as information rather than as a nuisance Replied, post #71 · Evidence › Meta-analyses · 21 Jan 2026 · 0 likes On post #67 — agreed on the reasoning, with one qualification. Why forest plots are more informative than pooled numbers: they show the variation across studies, which…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #81 · Clinical › Special populations · 21 Jan 2026 · 22 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #35 · Devices › Pens & autoinjectors · 29 Dec 2025 · 0 likes Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the dose counter is important if visibility is limited.
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #94 · Compounds › Oral incretins · 16 Dec 2025 · 6 likes I read post #92 twice before replying, because I had assumed the opposite. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and…
-
Sulfonylureas: the interaction most worth taking seriously Started this topic · Practice › Interactions · 14 Dec 2025 · 19 likes Sulfonylureas: the interaction most worth taking seriously Writing it up because I had to work it out twice and would rather nobody else did. Practical question with…
-
Run-in periods and the population they select Replied, post #35 · Evidence › Trials · 14 Dec 2025 · 24 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
DXA precision and the least significant change for lean mass Replied, post #59 · Outcomes › Body composition · 11 Dec 2025 · 1 like Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Tracking a preprint to publication: a worked example Replied, post #81 · Evidence › Preprints · 8 Dec 2025 · 5 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Cross-border purchase rules within the EU Replied, post #49 · Regional › European Union · 4 Dec 2025 · 2 likes Picking up post #46: that is the part I would want checked first. Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict…
-
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #21 · Practice › Side effects · 25 Nov 2025 · 20 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Robustness: the parameters worth deliberately varying Replied, post #13 · Analytics › Method validation · 21 Nov 2025 · 3 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Lurking for two months before posting: was that the right call? Replied, post #69 · Start Here › Welcome · 21 Nov 2025 · 0 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Pen dose counters: what a click does and does not guarantee Replied, post #117 · Devices › Pens & autoinjectors · 20 Nov 2025 · 20 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #95 · Compounds › Tirzepatide · 17 Nov 2025 · 0 likes post #94 is right about the mechanism and I think understates the practical bit. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #76 · Compounds › Tirzepatide · 15 Nov 2025 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] What steady state means for the decision to escalate Replied, post #89 · Practice › Dosing & titration · 14 Nov 2025 · 10 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Long-time reader, first-time poster Replied, post #10 · Lounge › Introductions · 9 Nov 2025 · 18 likes I read post #8 twice before replying, because I had assumed the opposite. Community culture: introductions give you a sense of who is here. Reading a few introduces you…
-
Trust level 3 requirements: a clarification Replied, post #15 · Meta › Announcements · 5 Nov 2025 · 0 likes Picking up post #12: that is the part I would want checked first. Implementation timeline: announcements include when a change takes effect. Marking the date helps you…
-
Payment mechanics and the recovery options that do not exist Replied, post #49 · Sourcing › Payments · 21 Oct 2025 · 0 likes Coming back to post #47, because the follow-up matters more than the original answer. Currency conversion: payment in your local currency often involves a conversion…
-
Second pass at: The mass-error checker and its intended scope Replied, post #42 · Data & Tools › Calculators · 19 Oct 2025 · 8 likes Worth separating two things that post #38 runs together. Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses…
-
Micronutrient adequacy at low total intake — does this still hold? Replied, post #15 · Nutrition & Training › Protein & intake · 6 Oct 2025 · 26 likes I read post #13 twice before replying, because I had assumed the opposite. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit…
-
Insurance and replacement policies, compared — the long version Replied, post #23 · Sourcing › Logistics · 5 Oct 2025 · 10 likes Worth separating two things that post #19 runs together. Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #4 · Evidence › Trials · 4 Oct 2025 · 0 likes I read post #2 twice before replying, because I had assumed the opposite. Dropout is information: high dropout rates can indicate tolerability problems or lower…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #26 · Practice › Interactions · 3 Oct 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Waist circumference technique and its repeatability Replied, post #4 · Outcomes › Progress reports · 3 Oct 2025 · 0 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
Follow-up: Why appetite effects are mostly central Replied, post #51 · Pharmacology › Receptor biology · 26 Sep 2025 · 10 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Titles that describe the question, not the situation — what changed since Replied, post #30 · Start Here › How to Ask · 20 Sep 2025 · 9 likes I read post #28 twice before replying, because I had assumed the opposite. Lab result questions: state the result, the reference interval, and what else is on the same…
-
Critiquing an observational claim about a class effect — one year on Replied, post #5 · Evidence › Study critique · 17 Sep 2025 · 12 likes I read post #3 twice before replying, because I had assumed the opposite. Criticise the method, not the author: a paper with a weak design is not a bad paper by someone…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #82 · Clinical › Special populations · 16 Sep 2025 · 13 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #38 · Practice › Side effects · 5 Sep 2025 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #5 · Analytics › Home & field testing · 1 Sep 2025 · 4 likes Picking up post #2: that is the part I would want checked first. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #57 · Evidence › Journal club · 29 Aug 2025 · 5 likes On post #53 — agreed on the reasoning, with one qualification. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence…
-
Pooling trials with different estimands — what changed since Replied, post #16 · Evidence › Meta-analyses · 23 Aug 2025 · 0 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
When a preprint is the best available evidence and we say so Replied, post #69 · Evidence › Preprints · 18 Aug 2025 · 22 likes Picking up post #66: that is the part I would want checked first. Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #26 · Evidence › Journal club · 17 Aug 2025 · 0 likes I read post #24 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #41 · Practice › Reconstitution · 9 Aug 2025 · 7 likes I read post #39 twice before replying, because I had assumed the opposite. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #103 · Practice › Storage & stability · 3 Aug 2025 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
A field-by-field walk through a certificate of analysis Replied, post #147 · Analytics › COA interpretation · 18 Jul 2025 · 28 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #83 · Clinical › Comorbidities · 5 Jul 2025 · 0 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #42 · Data & Tools › Calculators · 4 Jul 2025 · 1 like Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Started this topic · Analytics › HPLC & UHPLC · 1 Jul 2025 · 20 likes Posting this under the heading it deserves: Resolution and tailing factor: real acceptance criteria Everything below is what sits behind that. Posting the method first,…
-
Repeatability versus intermediate precision Replied, post #24 · Analytics › Method validation · 20 Jun 2025 · 5 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Repeatability versus intermediate precision Replied, post #8 · Analytics › Method validation · 17 Jun 2025 · 19 likes post #7 is right about the mechanism and I think understates the practical bit. Linearity: the detector response is proportional to compound concentration across the…
-
What a 2 ppm match establishes, and what it does not Replied, post #25 · Analytics › Mass spectrometry · 13 Jun 2025 · 7 likes Picking up post #22: that is the part I would want checked first. Desalting before analysis: some samples need desalting to remove salts that suppress the peptide…
-
A claim built entirely on a subgroup analysis Replied, post #60 · Evidence › Study critique · 28 May 2025 · 1 like When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #91 · Compounds › Tirzepatide · 22 May 2025 · 20 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #43 · Research Methods › N-of-1 designs · 22 May 2025 · 14 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Follow-up: Documentation that appears only after payment Replied, post #52 · Sourcing › Red flags · 6 May 2025 · 9 likes Picking up post #49: that is the part I would want checked first. Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #106 · Compounds › Semaglutide · 6 May 2025 · 0 likes This follows post #103 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #66 · Practice › Reconstitution · 4 May 2025 · 1 like post #65 is right about the mechanism and I think understates the practical bit. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
-
When to stop reading forums, including this one — the long version Replied, post #7 · Wellbeing › Mental health · 2 May 2025 · 7 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
Reading a trial's population section before its results — does this still hold? Replied, post #40 · Evidence › Trials · 25 Apr 2025 · 7 likes Coming back to post #38, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #45 · Practice › Interactions · 12 Apr 2025 · 18 likes This follows post #42 rather than contradicting it. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them…
-
Shakes versus food: a pragmatic assessment — the long version Started this topic · Nutrition & Training › Protein & intake · 12 Apr 2025 · 0 likes On the subject in the title: Shakes versus food: a pragmatic assessment — the long version Working notes rather than a conclusion. Maintenance rather than loss, which…
-
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #5 · Wellbeing › Mental health · 27 Mar 2025 · 5 likes post #4 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #126 · Access › International · 27 Mar 2025 · 10 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #34 · Wellbeing › Mental health · 24 Mar 2025 · 10 likes Coming back to post #32, because the follow-up matters more than the original answer. Body image and weight loss: large weight loss changes a person's relationship with…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #116 · Analytics › COA interpretation · 23 Mar 2025 · 0 likes On post #112 — agreed on the reasoning, with one qualification. When a document puts the specification in the result column, it has told you the release criterion, not…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #111 · Sourcing › Regulatory · 22 Mar 2025 · 22 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Validating a method you did not develop — does this still hold? Replied, post #132 · Analytics › Method validation · 18 Mar 2025 · 6 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Validating a method you did not develop — does this still hold? Replied, post #103 · Analytics › Method validation · 12 Mar 2025 · 0 likes This follows post #100 rather than contradicting it. Why two laboratories may disagree: after validating the same method, they may still report different purity on the…
-
Follow-up: What other technical communities get right that we do not Replied, post #37 · Lounge › Off topic · 12 Mar 2025 · 25 likes post #36 answers the question as asked. The question underneath it is different. Industry and supply chain: post about manufacturing, pharmaceutical economics, or…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #65 · Devices › Cold chain · 11 Mar 2025 · 31 likes Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range or if journey time is long. Insulated travel cases with…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #28 · Access › Pricing · 8 Mar 2025 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #81 · Compounds › Semaglutide · 28 Feb 2025 · 2 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Consistent declarations and why they matter more than clever ones Replied, post #95 · Sourcing › Logistics · 27 Feb 2025 · 0 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
How compounding permissions changed when supply normalised Replied, post #21 · Sourcing › Regulatory · 19 Feb 2025 · 0 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #29 · Compounds › Oral incretins · 12 Feb 2025 · 20 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #49 · Practice › Side effects · 11 Feb 2025 · 23 likes post #48 answers the question as asked. The question underneath it is different. Gallbladder complications: rapid weight loss increases the risk of gallstone formation.…
-
Canadian access and provincial variation Replied, post #60 · Regional › North America · 6 Feb 2025 · 17 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
-
Coming back to: Official shortage notices and what they authorise Started this topic · Access › Shortages · 3 Feb 2025 · 13 likes Official shortage notices and what they authorise — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail…
-
Identical chromatograms across two different lots Replied, post #75 · Sourcing › Red flags · 12 Jan 2025 · 33 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Oxidation pathways for methionine and tryptophan Replied, post #51 · Analytics › Impurities & related substances · 30 Dec 2024 · 7 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #8 · Evidence › Meta-analyses · 20 Dec 2024 · 8 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Washout with a one-week half-life: the arithmetic Replied, post #95 · Research Methods › N-of-1 designs · 9 Dec 2024 · 0 likes This follows post #92 rather than contradicting it. Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #51 · Evidence › Journal club · 5 Dec 2024 · 23 likes post #50 answers the question as asked. The question underneath it is different. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
Why "any advice?" is the least effective ending for a post Replied, post #101 · Start Here › How to Ask · 3 Dec 2024 · 3 likes Picking up post #98: that is the part I would want checked first. Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is…
-
The topic list is dense — is that deliberate? Replied, post #61 · Meta › Site feedback · 3 Dec 2024 · 1 like Search and findability: if you searched for something and did not find it, report what you searched for and what you expected to find. That helps improve indexing and…
-
Revisiting: Moderation log format change Replied, post #49 · Meta › Announcements · 1 Dec 2024 · 21 likes I read post #47 twice before replying, because I had assumed the opposite. RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #7 · Evidence › Trials · 28 Nov 2024 · 4 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Turnaround times and what they mean for a decision — one year on Replied, post #17 · Sourcing › Independent verification · 27 Nov 2024 · 25 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #44 · Meta › Wiki maintenance · 22 Nov 2024 · 28 likes Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity. Pointing out redundancy helps maintainers see the issue.
-
Request: a diff view for wiki revisions Replied, post #25 · Meta › Feature requests · 20 Nov 2024 · 29 likes Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why you think it would improve the site.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #95 · Clinical › Prescriber conversations · 8 Nov 2024 · 0 likes What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any adverse effects you have experienced with other…
-
[2026 update] Comparing tirzepatide and semaglutide is harder than the tables suggest Replied, post #3 · Compounds › Tirzepatide · 4 Nov 2024 · 30 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #140 · Clinical › Bloodwork · 24 Oct 2024 · 22 likes Picking up post #137: that is the part I would want checked first. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #13 · Meta › Wiki maintenance · 20 Oct 2024 · 17 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #107 · Clinical › Bloodwork · 14 Oct 2024 · 13 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #113 · Access › Shortages · 13 Oct 2024 · 30 likes Worth separating two things that post #109 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Promotion criteria, and the one that stops most nominations Replied, post #69 · Documentation › Doc review · 24 Sep 2024 · 0 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
-
Circumference measurements as a poor man's composition estimate Replied, post #26 · Outcomes › Body composition · 28 Jul 2024 · 25 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Guidelines revision: what changed and why Replied, post #45 · Meta › Announcements · 26 Jul 2024 · 14 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #59 · Evidence › Journal club · 24 Jul 2024 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #13 · Compounds › Retatrutide · 16 Jul 2024 · 16 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #53 · Practice › Dosing & titration · 8 Jul 2024 · 27 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #5 · Evidence › Journal club · 6 Jul 2024 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
How this community labels and discusses unrefereed work Replied, post #46 · Evidence › Preprints · 28 Jun 2024 · 30 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…